Cargando…

FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness

OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llauradó, Gemma, Megia, Ana, Cano, Albert, Giménez-Palop, Olga, Simón, Inmaculada, González-Sastre, Montserrat, Berlanga, Eugenio, Fernández-Veledo, Sonia, Vendrell, Joan, González-Clemente, José-Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604080/ https://www.ncbi.nlm.nih.gov/pubmed/26462160 http://dx.doi.org/10.1371/journal.pone.0140222

Ejemplares similares

Arterial Stiffness in Type 1 Diabetes: The Case for the Arterial Wall Itself as a Target Organ
por: González-Clemente, José-Miguel, et al.
Publicado: (2021)

Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM
por: Llauradó, Gemma, et al.
Publicado: (2019)

Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance
por: Llauradó, Gemma, et al.
Publicado: (2017)

Utility of Insulin Resistance in Estimating Cardiovascular Risk in Subjects with Type 1 Diabetes According to the Scores of the Steno Type 1 Risk Engine
por: Cano, Albert, et al.
Publicado: (2020)

Specific Nuclear Magnetic Resonance Lipoprotein Subclass Profiles and Central Arterial Stiffness in Type 1 Diabetes Mellitus: A Case Control Study
por: Llauradó, Gemma, et al.
Publicado: (2019)

Arterial Stiffness Is Increased in Patients With Type 1 Diabetes Without Cardiovascular Disease: A potential role of low-grade inflammation
por: Llauradó, Gemma, et al.
Publicado: (2012)

Erratum. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019;42:1956–1965
por: Ceperuelo-Mallafré, Victoria, et al.
Publicado: (2019)

Impaired Succinate Response to a Mixed Meal in Obesity and Type 2 Diabetes Is Normalized After Metabolic Surgery
por: Astiarraga, Brenno, et al.
Publicado: (2020)

Evaluation of the Role of FGF23 in Mineral Metabolism
por: Yokota, Hiroki, et al.
Publicado: (2009)

Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23
por: Pons-Belda, Oscar D., et al.
Publicado: (2023)

Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study
por: Llauradó, Gemma, et al.
Publicado: (2012)

The ANGPTL3-4-8 Axis in Normal Gestation and in Gestational Diabetes, and Its Potential Involvement in Fetal Growth
por: Klid, Sergiy, et al.
Publicado: (2023)

Gestational diabetes impacts fetal precursor cell responses with potential consequences for offspring
por: Algaba‐Chueca, Francisco, et al.
Publicado: (2019)

Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease
por: Albanese, Luisa, et al.
Publicado: (2022)

Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study
por: Rodríguez‐Peña, M‐Mar, et al.
Publicado: (2021)

Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients
por: Bouksila, Mouna, et al.
Publicado: (2019)

Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?
por: Fernández-Veledo, Sonia, et al.
Publicado: (2019)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
por: Mace, Maria L., et al.
Publicado: (2020)

DNA Methylation in Gestational Diabetes and its Predictive Value for Postpartum Glucose Disturbances
por: Ballesteros, Mónica, et al.
Publicado: (2022)

FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease
por: Kurpas, Anna, et al.
Publicado: (2021)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019)

The angiogenic properties of human amniotic membrane stem cells are enhanced in gestational diabetes and associate with fetal adiposity
por: Klid, Sergiy, et al.
Publicado: (2021)

Cord Blood Advanced Lipoprotein Testing Reveals an Interaction between Gestational Diabetes and Birth-Weight and Suggests a New Early Biomarker of Infant Obesity
por: Algaba-Chueca, Francisco, et al.
Publicado: (2022)

Correction: The angiogenic properties of human amniotic membrane stem cells are enhanced in gestational diabetes and associate with fetal adiposity
por: Klid, Sergiy, et al.
Publicado: (2023)

High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
por: Gravesen, Eva, et al.
Publicado: (2013)

Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
por: Murali, Sathish K., et al.
Publicado: (2016)

Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice
por: Daryadel, Arezoo, et al.
Publicado: (2019)

Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis
por: Cano, Francisco J., et al.
Publicado: (2014)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Zinc-α2-Glycoprotein Is Unrelated to Gestational Diabetes: Anthropometric and Metabolic Determinants in Pregnant Women and Their Offspring
por: Näf, Silvia, et al.
Publicado: (2012)

Is there a role in acute kidney injury for FGF23 and Klotho?
por: Mattinzoli, Deborah, et al.
Publicado: (2023)

Salivary Cortisol Determination in ACTH Stimulation Test to Diagnose Adrenal Insufficiency in Patients with Liver Cirrhosis
por: Albert, Lara, et al.
Publicado: (2019)

Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder
por: Hussain, Imran, et al.
Publicado: (2023)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oc0r2pj2ugqn9vc0t3ujgqakq6